Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway-Reference-Cited by-同舟云学术

Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway

Published:2021-06 Issue: Volume:188 Page:114538
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Wang Fangfang,Huang Jingcao,Guo Tingting,Zheng Yuhuan,Zhang Li,Zhang Dan,Wang Fujue,Naren Duolan,Cui Yushan,Liu Xiaoyan,Qu Ying,Luo Hongmei,Yang Yan,Wei Haichen,Guo Yong

Funder

Science and Technology Department of Sichuan Province

Sichuan Province Department of Health

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference33 articles.

1. Acute myeloid leukaemia genomics;Medinger;Br. J. Haematol.,2017

2. Prognostically useful gene-expression profiles in acute myeloid leukemia;Valk;N. Engl. J. Med.,2004

3. Structural and functional alterations of FLT3 in acute myeloid leukemia;Meshinchi;Clin. Cancer Res.,2009

4. Prognostic significance of FLT3 ITD and D835 mutations in AML patients;Sheikhha;Hematol. J.,2003

5. Clinical significance of FLT3 in leukemia;Kiyoi;Int. J. Hematol.,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homoharringtonine: updated insights into its efficacy in hematological malignancies, diverse cancers and other biomedical applications;European Journal of Medical Research;2024-05-04

2. ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?;Biomedicines;2024-01-05

3. Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial;Frontiers in Oncology;2023-08-18

4. ACC010 , a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3 ‐ ITD ;Molecular Oncology;2023-01-21

5. Ibrutinib Prevents Acute Lung Injury via Multi-Targeting BTK, FLT3 and EGFR in Mice;International Journal of Molecular Sciences;2022-11-03